What does a low hsCRP level mean?

A low hsCRP level (below 1.0 mg/L) indicates minimal inflammation in your body and suggests a lower risk of cardiovascular disease and other inflammatory conditions. This is generally a positive sign of good health, though extremely low levels warrant discussion with your healthcare provider.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding hsCRP and Its Role in Your Body

High-sensitivity C-reactive protein (hsCRP) is a protein produced by your liver in response to inflammation throughout your body. Unlike standard CRP tests, the high-sensitivity version can detect even small amounts of this protein, making it particularly valuable for assessing cardiovascular disease risk and overall inflammatory status.

When your hsCRP levels are low, it typically means your body is experiencing minimal inflammation. This is generally good news, as chronic inflammation is linked to numerous health conditions, including heart disease, diabetes, and certain cancers. Understanding your hsCRP levels can provide valuable insights into your overall health status and help guide preventive health strategies.

What Are Normal and Low hsCRP Ranges?

Healthcare providers typically categorize hsCRP levels into three main risk categories for cardiovascular disease. Understanding where your levels fall can help you and your healthcare team make informed decisions about your health management.

hsCRP Risk Categories for Cardiovascular Disease

hsCRP Level (mg/L)Risk CategoryInterpretationRecommended Actions
Below 1.0<1.0 mg/LLow RiskMinimal inflammation, favorable cardiovascular profileMaintain healthy lifestyle, regular monitoring
1.0-3.01.0-3.0 mg/LModerate RiskAverage inflammation, intermediate cardiovascular riskLifestyle modifications, consider additional testing
Above 3.0>3.0 mg/LHigh RiskElevated inflammation, increased cardiovascular riskMedical evaluation, aggressive risk factor modification
Above 10.0>10.0 mg/LAcute InflammationLikely acute infection or injuryRetest after recovery, seek medical attention if persistent

Risk categories based on American Heart Association guidelines. Individual risk assessment should consider multiple factors.

A low hsCRP level is generally defined as anything below 1.0 mg/L. Some laboratories and healthcare providers may use slightly different reference ranges, but values in this range consistently indicate low inflammation and reduced cardiovascular risk. Optimal levels are often considered to be below 0.5 mg/L, though any reading under 1.0 mg/L is typically viewed favorably.

Factors That Influence hsCRP Levels

Several factors can affect your hsCRP levels, including:

  • Body weight and composition
  • Physical activity levels
  • Diet quality and specific food choices
  • Smoking status
  • Alcohol consumption
  • Stress levels
  • Sleep quality and duration
  • Certain medications (statins, NSAIDs, aspirin)
  • Genetic factors

Health Benefits of Low hsCRP Levels

Maintaining low hsCRP levels is associated with numerous health benefits. Research has consistently shown that individuals with lower inflammatory markers tend to have better overall health outcomes and reduced risk of chronic diseases.

Cardiovascular Protection

Low hsCRP levels are strongly associated with reduced cardiovascular disease risk. Studies have shown that people with hsCRP levels below 1.0 mg/L have significantly lower rates of heart attacks, strokes, and other cardiovascular events compared to those with higher levels. This protective effect appears to be independent of other traditional risk factors like cholesterol levels.

The relationship between hsCRP and cardiovascular health is so well-established that many cardiologists now routinely include hsCRP testing as part of comprehensive cardiovascular risk assessment. When combined with other biomarkers like cholesterol panels and blood pressure measurements, hsCRP provides a more complete picture of your heart health.

Reduced Risk of Chronic Diseases

Beyond cardiovascular benefits, low hsCRP levels are associated with reduced risk of several other chronic conditions:

  • Type 2 diabetes
  • Metabolic syndrome
  • Certain types of cancer
  • Autoimmune conditions
  • Neurodegenerative diseases
  • Chronic kidney disease

When Low hsCRP Might Be Concerning

While low hsCRP levels are generally positive, extremely low levels (near zero) in certain contexts might warrant further investigation. In rare cases, very low CRP production could indicate:

  • Liver dysfunction (since CRP is produced in the liver)
  • Certain genetic variations affecting CRP production
  • Immune system suppression
  • Effects of certain medications

However, it's important to note that these situations are uncommon. For most people, low hsCRP levels simply reflect good health and low inflammatory burden. If you have concerns about extremely low levels, discuss them with your healthcare provider in the context of your overall health picture.

How to Maintain Low hsCRP Levels

If you already have low hsCRP levels, maintaining them through healthy lifestyle choices can help preserve your cardiovascular and overall health. Here are evidence-based strategies to keep inflammation low:

Dietary Approaches

  • Follow an anti-inflammatory diet rich in fruits, vegetables, whole grains, and omega-3 fatty acids
  • Limit processed foods, refined sugars, and trans fats
  • Include foods high in antioxidants like berries, leafy greens, and nuts
  • Consider the Mediterranean diet pattern, which has been shown to reduce hsCRP levels
  • Stay adequately hydrated
  • Moderate alcohol consumption or avoid it entirely

Lifestyle Modifications

  • Engage in regular physical activity (at least 150 minutes of moderate exercise per week)
  • Maintain a healthy body weight
  • Prioritize quality sleep (7-9 hours per night)
  • Manage stress through meditation, yoga, or other relaxation techniques
  • Avoid smoking and secondhand smoke exposure
  • Practice good oral hygiene, as gum disease can increase inflammation

Testing and Monitoring Your hsCRP Levels

Regular monitoring of hsCRP can be valuable for tracking your inflammatory status and cardiovascular risk over time. The American Heart Association recommends hsCRP testing for individuals at intermediate risk for cardiovascular disease, though many health-conscious individuals choose to monitor it as part of their preventive health strategy.

When getting tested, keep in mind that hsCRP levels can be temporarily elevated due to acute infections, injuries, or intense physical activity. For the most accurate results, test when you're feeling well and haven't had any recent illnesses or injuries. Some healthcare providers recommend testing twice, about two weeks apart, and using the average of the two results.

For comprehensive health monitoring, consider testing hsCRP alongside other inflammatory and cardiovascular markers. This broader panel can provide deeper insights into your metabolic health and help identify areas for improvement even when individual markers appear normal.

The Bigger Picture: hsCRP in Context

While low hsCRP levels are certainly positive, it's important to view this marker in the context of your overall health profile. hsCRP is just one piece of the puzzle when it comes to assessing cardiovascular risk and inflammatory status. Other important factors include:

  • Traditional cardiovascular risk factors (blood pressure, cholesterol levels, family history)
  • Other inflammatory markers (IL-6, TNF-alpha, fibrinogen)
  • Metabolic health indicators (fasting glucose, insulin sensitivity)
  • Lifestyle factors (diet, exercise, stress, sleep)
  • Personal and family medical history

Your healthcare provider can help interpret your hsCRP results alongside these other factors to create a comprehensive picture of your health status and develop appropriate preventive strategies.

Moving Forward with Low hsCRP Levels

Having low hsCRP levels is an excellent indicator of good health and low inflammatory burden. This favorable marker suggests your body is functioning well and your risk of cardiovascular disease and other inflammatory conditions is reduced. However, maintaining these healthy levels requires ongoing attention to lifestyle factors and regular monitoring.

Continue supporting your low inflammation status through healthy eating, regular exercise, stress management, and quality sleep. Consider periodic retesting to ensure your levels remain optimal, especially if you make significant lifestyle changes or develop new health concerns. Remember that while low hsCRP is positive, it's most meaningful when considered alongside other health markers and in the context of your overall wellness strategy.

References

  1. Ridker, P. M. (2016). A Test in Context: High-Sensitivity C-Reactive Protein. Journal of the American College of Cardiology, 67(6), 712-723.[Link][DOI]
  2. Emerging Risk Factors Collaboration. (2010). C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. The Lancet, 375(9709), 132-140.[PubMed][DOI]
  3. Pearson, T. A., et al. (2003). Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107(3), 499-511.[PubMed][DOI]
  4. Kushner, I., Rzewnicki, D., & Samols, D. (2006). What does minor elevation of C-reactive protein signify? The American Journal of Medicine, 119(2), 166.e17-166.e28.[PubMed][DOI]
  5. Ridker, P. M., et al. (2017). Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. New England Journal of Medicine, 377(12), 1119-1131.[PubMed][DOI]
  6. Koenig, W. (2018). C-Reactive Protein and Cardiovascular Risk: Will the Controversy End After CANTOS? Clinical Chemistry, 64(12), 1718-1727.[PubMed][DOI]

Frequently Asked Questions

How can I test my hsCRP at home?

You can test your hsCRP at home with SiPhox Health's Core Health Program, which includes hsCRP testing along with other essential cardiovascular and metabolic markers. This CLIA-certified program provides lab-quality results from the comfort of your home, making it easy to monitor your inflammatory status regularly.

Can hsCRP levels be too low?

While extremely rare, very low hsCRP levels (near zero) could potentially indicate liver dysfunction or certain genetic variations. However, for the vast majority of people, low hsCRP levels simply reflect good health and minimal inflammation. If you have concerns about unusually low levels, discuss them with your healthcare provider.

How often should I test my hsCRP levels?

For most people, testing hsCRP every 3-6 months is sufficient to monitor trends and assess the effectiveness of lifestyle interventions. If you're actively working to reduce inflammation or have cardiovascular risk factors, more frequent testing (every 3 months) may be beneficial. Those with stable, low levels might only need annual testing.

What's the difference between CRP and hsCRP?

Standard CRP tests measure higher levels of inflammation typically associated with acute infections or injuries. hsCRP (high-sensitivity CRP) can detect much lower levels of inflammation, making it more useful for assessing cardiovascular risk and chronic low-grade inflammation. The 'high-sensitivity' refers to the test's ability to detect small amounts of CRP, not higher levels.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details